Generic Pharma Trading Proprietary Company

This company owns 22 trademarked medicine brand names that are used in treating several diabetic, cardiac (including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), hypertension, narcolepsy, Parkinson’s, dyslipidemia, schizophrenia, depression, mania, all neuropathy and neuro-related disorders.

Value Drivers

• Extremely Low Overheads
• Fixed Set of Supply Chain Intermediaries as Customers
  • Procurement Set in Place
  • Trademarks Ownership
  • Super Profit Margins
• Wide Range of Medicines as Products

Reason for Sale

The primary owner wishes to retire early and invest the sales proceeds for passive income mainly due to their health condition that needs more relaxation.

Team

The team consists of the owner as the CEO.

• There are 4 on-field sales personnel focused on business development through hospitals and clinics.
• There is 1 administrative staff for office-based tasks.

Business Model

• Buying pills from third-party contract manufacturers.
• Markets it under its brand name and trademarked individual product names.
• Sell at major pharmacies throughout the state along with sales on major e-pharmacists such as 1mg, and Apollo.

The company is modestly priced in comparison to the generic pharma trading multiples in India.